TERAGENIX

biological agents, namely, vectors and retroviral vectors, for use in in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries; vector and retroviral vector manufacturing preparations, all for use in diagnostic and biopharmaceutical technology; molecular diagnostic preparations containing nucleic acids for assistance in manufacturing controls and/or reagents; and molecular and biopharmaceutical chemicals and biochemical preparations and solutions for use in the in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industry

laboratory products, medical devices and quality control products, namely, controls, calibrators, standards and panels for the in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries

medical diagnostic equipment, namely, diagnostic test kits and subcomponents of diagnostic test kits such as controls, calibrators, standards and reagents